INNATE PHARMA SA (IPH.PA) 2.834 +0.06 (+2.31%)
2.834 +0.06 (+2.31%)
FR0010331421 - Common Stock
Technical Rating
We assign a technical rating of 0 out of 10 to IPH. IPH scores bad on all fronts: it is a bad performer in the overall market and both the medium and short term pictures are negative.
IPH is one of the better performing stocks in the Biotechnology industry, it outperforms 72% of 50 stocks in the same industry.
In the last month IPH has a been trading in the 2.49 - 2.96 range, which is quite wide. It is currently trading in the middle of this range, so some resistance may be found above.
The long term trend is still negative, but the short term trend is neutral. It is advised to wait a little bit longer to see how this turns out.
When comparing the yearly performance of all stocks, IPH is a bad performer in the overall market: 77% of all stocks are doing better.
IPH is currently trading near the lower end of its 52 week range, which is not a good sign. But, the S&P500 Index is also trading in the lower part of its yearly range, so IPH is not an exception.
Considerably lower volume is observed in the last couple of days, which is not what you would like to see during a strong up movement.
Statistics
Support/Resistance Analysis
2.47
3.20
When analyzing the support we notice one important area.
- Support @2.49 from a horizontal line in the daily time frame.
We can see 3 important resistance areas.
- A resistance zone ranging from 2.85 to 2.89. This zone is formed by a combination of multiple trend lines and important moving averages in the daily time frame.
- Resistance @3.01 from a trend line in the daily time frame.
- A resistance zone ranging from 3.14 to 3.17. This zone is formed by a combination of multiple trend lines in multiple time frames.
Setup Analysis
Setup Rating
Although the technical rating is bad, IPH does present a nice setup opportunity. We see reduced volatility while prices have been consolidating in the most recent period.
INNATE PHARMA SA2.834
EPA:IPH (5/16/2022, 5:27:41 PM)+0.06 (+2.31%)
| GICS Sector | Health Care | ||
| GICS Industry | Biotechnology | ||
| Today | 2.31% | 1 Week | 13.45% |
| 2 Weeks | 5.75% | 1 Month | -1.25% |
| 3 Month | -11.05% | 6 Month | -35.33% |
| ATR(14) | 0.14 | ATR(20)% | 4.3% |
| ATR Inc | -5.21% | Range Today | 0.07 |
| ST Trend | LT Trend | ||
| SMA(5) | SMA(10) | ||
| SMA(20) | SMA(50) | ||
| SMA(100) | SMA(200) |
| CRS | 23.32 | Mansfield | -1.43 |
| 10 Day High | 2.84 | 10 Day Low | 2.49 |
| 20 Day High | 2.96 | 20 Day Low | 2.49 |
| 52 Week High | 8.28 | 52 Week Low | 2.44 |
| CS1 End | 2.49 | CR1 Start | 2.85 |
| DER(3) | 2.31% | DER(5) | 1.4% |
| Volume | 3.48K | Volume Incr | -26.8% |
| Vol(5) | 122.59K | Vol(50) | 205.55K |
Technical Stock Screener Links
Technical Stock Screener
Find stocks with similar TA and Setup ratings on the EuroNext
Best Technical Competitors Stock Screener
Find the competitors with the best technical ratings on the EuroNext
Best Technical Setups Competitors Stock Screener
Find the competitors with the best technical and setup ratings on the EuroNext